Stock Market News3 weeks Why Is Apellis Pharmaceuticals (APLS) Up 18.4% Since Last Earnings Report? Zacks
X3 weeks Are Options Traders Betting on a Big Move in Agios (AGIO) Stock? Zacks
X3 weeks The Weight-Loss Battle That Could Rattle Eli Lilly’s $100 Billion Market Investor's Business Daily
X3 weeks What Makes Alnylam (ALNY) a New Buy Stock Zacks
X3 weeks Why Is Vertex (VRTX) Down 8.6% Since Last Earnings Report? Zacks
X3 weeks Wall Street Analysts Think Tarsus Pharmaceuticals (TARS) Could Surge 26.98%: Read This Before Placing a Bet Zacks
X3 weeks Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know Zacks
X3 weeks Agios Pharmaceuticals: A Long Overdue Follow Up Seeking Alpha
X3 weeks Why Acadia Pharmaceuticals (ACAD) is a Top Momentum Stock for the Long-Term Zacks
X3 weeks Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock Zacks
X3 weeks Implied Volatility Surging for ACADIA Pharmaceuticals (ACAD) Stock Options Zacks
X3 weeks Terns Pharma broadens beyond obesity drugs with upbeat data in leukemia trial MarketWatch
X3 weeks Coherus BioSciences inks $558.4M deal with Intas Pharmaceuticals; shares rally Investing.com
X3 weeks Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock? Zacks
X3 weeks Rocket Pharmaceuticals: Not Bad Valuation But Reflexivity Risks Remain Seeking Alpha
X3 weeks Elite Pharmaceuticals Launches Norco in generic $ELTP Reddit
X4 weeks GILD vs. VRTX: Which Stock Should Value Investors Buy Now? Zacks
X4 weeks Mirum Shares Surge More Than 90% in 6 Months: Here’s Why Zacks
X4 weeks Wall Street Analysts Think Jazz (JAZZ) Could Surge 44.37%: Read This Before Placing a Bet Zacks
X4 weeks Arrowhead Pharmaceuticals Faces Distribution Risks with Vanscoy Reliance Yahoo Finance
X4 weeks Here’s Why Acurx Pharmaceuticals (ACXP) Is a Great ‘Buy the Bottom’ Stock Now Zacks
X4 weeks Ionis Pharmaceuticals (IONS) Upgraded to Buy: What Does It Mean for the Stock? Zacks
X4 weeks NRx Pharmaceuticals (NRXP) Upgraded to Buy: Here’s Why Zacks
X4 weeks SRPT Inks $11B Licensing Deal With Arrowhead for Rare Gene Therapies Zacks
X4 weeks ACAD Signs License Deal With Saniona for Rights to Neurology Drug Zacks
X4 weeks Despite Fast-paced Momentum, Sonoma Pharmaceuticals (SNOA) Is Still a Bargain Stock Zacks
X4 weeks Arrowhead Pharmaceuticals, Inc. (ARWR) Q4 2024 Earnings Call Transcript Seeking Alpha
X4 weeks Does ANI (ANIP) Have the Potential to Rally 31.31% as Wall Street Analysts Expect? Zacks
X4 weeks Is Agios Pharmaceuticals (AGIO) Stock Outpacing Its Medical Peers This Year? Zacks
X4 weeks FDA Begins Review of Alnylam’s sNDA for Expanded Amvuttra Use Zacks
X4 weeks Arrowhead, Sarepta Skyrocket After Duo Inks A Whopping $11.38 Billion Deal Investor's Business Daily
X4 weeks Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know Zacks
X4 weeks The Zacks Analyst Blog Costco, T-Mobile US, Uber Technologies, SandRidge and Elite Pharmaceuticals Zacks
X4 weeks Enanta Pharmaceuticals (ENTA) Reports Q4 Loss, Misses Revenue Estimates Zacks
X4 weeks Adial Pharmaceuticals (ADIL) Upgraded to Buy: Here’s What You Should Know Zacks
X4 weeks Do Options Traders Know Something About Regeneron (REGN) Stock We Don’t? Zacks
X1 month Ligand Pharmaceuticals: Buy This Strong Growing Pharma And Get A Stake In Dozens Of Therapies Seeking Alpha
X1 month Avadel Pharmaceuticals: Despite My Sympathies For The Company, Stock Looks Risky Seeking Alpha
X1 month Madrigal (MDGL) Just Flashed Golden Cross Signal: Do You Buy? Zacks
X1 month Is Atea Pharmaceuticals (AVIR) Stock Outpacing Its Medical Peers This Year? Zacks
X1 month Warren Buffett’s Stock Selling is Sending a Big Signal Zacks
X1 month JAZZ Secures FDA Approval for Ziihera in Biliary Tract Cancer Zacks
X1 month PFE vs. NVO: Which Stock Is the Better Value Option? Zacks
X1 month MCK Stock Down Despite Latest Partnership to Boost SCD Treatment Zacks
X1 month Sun Pharmaceuticals Elliott Wave technical analysis [Video] FXStreet
X1 month ANI (ANIP) Upgraded to Buy: What Does It Mean for the Stock? Zacks
X1 month ARS Pharmaceuticals: Demand Curve Is Key Unknown Seeking Alpha
X1 month Acurx to add up to $1 million in bitcoin for treasury reserve, following MicroStrategy’s playbook CNBC
X1 month Is Trending Stock AbbVie Inc. (ABBV) a Buy Now? Zacks
XThe Stock Market News
TheStockMarketNews.com is a financial news aggregator for traders and investors that proposes to you the latest breaking news headlines on global financial markets, economy and business. Live trading analysis, opinions and forecasts on current stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs, funds, bonds, rates and more. Disclaimer: by using any material of this website, you acknowledge and agree that TheStockMarketNews.com is not responsible for the content, actions or any legal issues arising from third-party websites; materials of this website are not financial advice or call to actions. Trading and investing in financial instruments involve high risks including the risk of investment loss.